Ontario HBOT - Hyperbaric Oxygen Therapy Ontario - Treating Toronto, GTA, York Region, Southern Ontario, Mississauga - Hyperbaric Oxygen Therapy Clinic in Toronto Ontario Canada - Oxygen Under Pressure

Over the past two decades, extensive international medical research has demonstrated that hyperbaric oxygen therapy (HBOT) can play an extremely important role in the treatment of multiple sclerosis. In many European countries, HBOT is now considered an integral part of the MS treatment program. Note: Permission has been granted by the author to use this article.
>>Click here to read full article...

There is no standardized approved medical treatment for autism. Families raising an autistic child spend countless hours researching virtually every available treatment that may improve the health and quality of life for their child. Hyperbaric Oxygen Therapy (HBOT) is one of the newest and most promising therapies for autism. Note: Permission has been granted by the author to use this article.
>>Click here to read the full article...

In more than 7,000 facilities worldwide, hyperbaric oxygen therapy (HBOT) has been used for decades to heal serious infections, non-healing wounds, and to treat divers with the bends.

An increasing number of these hyperbaric medical centers are also successfully treating neurological injuries and disease such as autism.

Recent studies have suggested that a common link among children with autism is chronic inflammation of areas of the brain and gut, and that the anti-inflammatory effects of HBOT may make it one of the safest and most effective ways to help resolve the debilitating effects of autism.

>> Click Here to read the full report.

"Announcement of a New Treatment Protocol for Autism Spectrum Disorders and other Neurological Impairments" The International Hyperbaric Medical Association Foundation Paul Harch, M.D. President Before the Government Reform & Oversight Hearing --Subcommittee on Wellness & Human Rights Entitled
"Autism Spectrum Disorders: An Update of Federal Government Initiatives and Revolutionary New Treatments of Neurodevelopmental Diseases "
United States House of Representatives May 6, 2004, 2:00PM
>> Click Here to read Dr. Paul Harch's full testimony.